Literature DB >> 216703

Stimulation of human foreskin fibroblast adenosine 3':5'-cyclic monophosphate levels by prostacyclin (prostaglandin I2).

R R Gorman, R D Hamilton, N K Hopkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216703

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  8 in total

1.  Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin.

Authors:  Pascale Gluais; Michel Lonchampt; Jason D Morrow; Paul M Vanhoutte; Michel Feletou
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase.

Authors:  M Zou; M Jendral; V Ullrich
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 3.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

4.  Effect of prostaglandin E1 on pulmonary circulation in pulmonary atresia. A quantitative morphometric study.

Authors:  S G Haworth; U Sauer; K Bühlmeyer
Journal:  Br Heart J       Date:  1980-03

5.  Prostacyclin as a potent effector of adipose-cell differentiation.

Authors:  R Négrel; D Gaillard; G Ailhaud
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

6.  Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.

Authors:  N K Hopkins; R R Gorman
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

7.  Relationship between prostacyclin biosynthesis and cyclic AMP in cultured rabbit mesothelial cells.

Authors:  V J Van de Velde; H Bult; A G Herman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-04       Impact factor: 3.000

8.  Prostacyclin.

Authors:  J R Vane
Journal:  J R Soc Med       Date:  1983-04       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.